Altinoy Kamilova | Medicine and Dentistry | Best Review Article Award

Published on by Best Paper Awards

Best Review Article Award

Altinoy Kamilova

Republican Specialized Scientific and Practical Medical Center of Pediatrics, Uzbekistan

Altinoy Kamilova
Affiliation Republican Specialized Scientific and Practical Medical Center of Pediatrics
Country Uzbekistan
Scopus ID 6603459264
Documents 41
Citations 65
h-index 4
Subject Area Medicine and Dentistry
Event International Research Excellence and Best Paper Awards
ORCID 0000-0003-1695-0978

Altinoy Kamilova is a medical researcher affiliated with the Republican Specialized Scientific and Practical Medical Center of Pediatrics in Uzbekistan. Her research contributions are associated with medicine, dentistry, pediatric healthcare, and the investigation of gastrointestinal disorders. Her review article, Biomarkers for Intestinal Damage in Pediatric Celiac Disease, addresses emerging approaches to identifying and monitoring intestinal injury in children affected by celiac disease. [1]

 Abstract

The review article Biomarkers for Intestinal Damage in Pediatric Celiac Disease examines the potential role of biological markers in assessing intestinal injury among children diagnosed with celiac disease. Celiac disease is an immune-mediated condition associated with gluten exposure in genetically susceptible individuals and can result in inflammation and damage to the small intestinal mucosa. Conventional diagnostic approaches include serological investigations and intestinal biopsy, but these methods have limitations in evaluating ongoing intestinal injury and monitoring mucosal recovery. [1]

Keywords

Celiac disease, pediatric medicine, biomarkers, intestinal damage, intestinal fatty acid-binding protein, citrulline, gluten immunogenic peptides, zonulin, fecal calprotectin, intestinal permeability, mucosal healing, gastrointestinal health, gluten-free diet, medical research, clinical biomarkers. [1]

 Introduction

Celiac disease is a chronic immune-mediated gastrointestinal disorder triggered by gluten consumption in individuals with a genetic predisposition. It can cause inflammation and structural changes in the small intestinal mucosa, potentially affecting nutrient absorption, growth, and overall health, particularly during childhood. Accurate diagnosis and continued monitoring are important components of pediatric disease management. [1]

Research Profile

Altinoy Kamilova is affiliated with the Republican Specialized Scientific and Practical Medical Center of Pediatrics, Uzbekistan. Her scholarly profile is represented in the medical and dentistry research domain, with a publication record and citation information identified through her Scopus author profile. Her ORCID identifier provides an additional persistent academic identity for research attribution and publication discovery. [2] [3]

 Research Contributions

The review article contributes to the scientific discussion of potential biomarkers for identifying intestinal damage and evaluating disease activity in pediatric celiac disease. It brings together different categories of biomarkers and considers their possible applications in clinical assessment and follow-up. [1]

 Publications

Altinoy Kamilova’s identified scholarly contribution includes a review article addressing biomarkers for intestinal damage in pediatric celiac disease. The publication examines diagnostic and monitoring approaches relevant to pediatric gastrointestinal research and highlights opportunities for further investigation into non-invasive clinical biomarkers. [1]

 Research Impact

Research into biomarkers for pediatric celiac disease has potential relevance to clinical diagnostics, gastrointestinal medicine, and long-term patient monitoring. Identifying reliable indicators of intestinal injury could help researchers and clinicians investigate disease activity, dietary adherence, and mucosal recovery. The review contributes to this research direction by bringing together findings from different biomarker categories. [1]

 Award Suitability

The Best Review Article Award recognizes scholarly review contributions that demonstrate academic relevance, critical engagement with scientific literature, clarity of presentation, and potential value to a research discipline. Review articles can contribute to scientific progress by organizing existing evidence, identifying research gaps, and highlighting emerging directions for future investigation.

Conclusion

Altinoy Kamilova’s research contribution to the review of biomarkers for intestinal damage in pediatric celiac disease represents a relevant scholarly contribution to pediatric medicine and gastrointestinal research. [1] [2]

References

  1. Usmonova, K., Kamilova, A., Geller, S., & Umarnazarova, Z. (2026). Biomarkers for intestinal damage in pediatric celiac disease. Frontiers in Pediatrics, 14, Article 2000459. Mini Review. DOI: 10.3389/fped.2026.2000459.
    https://doi.org/10.3389/fped.2026.2000459
  2. Elsevier. (n.d.). Scopus author details: Altinoy Kamilova, Author ID 6603459264. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6603459264
  3. ORCID. (n.d.). Altinoy Kamilova – ORCID researcher identifier 0000-0003-1695-0978. ORCID.
    https://orcid.org/0000-0003-1695-0978
  4. Best Paper Awards. (n.d.). Best Paper Awards – Official Website
    .https://bestpaperawards.com/

Komola Usmonova | Medicine and Dentistry | Best Review Article Award

Published on by Best Paper Awards

Best Review Article Award

Komola Usmonova

Republican Specialized Scientific and Practical Medical Center of Pediatrics, Uzbekistan.

Komola Usmonova
Affiliation Republican Specialized Scientific and Practical Medical Center of Pediatrics
Country Uzbekistan
Scopus ID 58924619100
Documents 1
Citations 1
h-index 1
Subject Area Medicine and Dentistry
Event International Research Excellence and Best Paper Awards

Komola Usmonova is a medical researcher affiliated with the Republican Specialized Scientific and Practical Medical Center of Pediatrics in Uzbekistan. Her research interests include pediatric medicine, gastrointestinal health, and the investigation of biomarkers associated with intestinal damage. Her scholarly contribution, Biomarkers for Intestinal Damage in Pediatric Celiac Disease, examines emerging approaches to identifying and monitoring intestinal injury in children affected by celiac disease. The article was published in Frontiers in Pediatrics in 2026 and has the DOI 10.3389/fped.2026.2000459.

Abstract

The review article Biomarkers for Intestinal Damage in Pediatric Celiac Disease examines emerging biomarkers for evaluating intestinal injury and monitoring disease activity in children with celiac disease. Celiac disease is an immune-mediated condition triggered by gluten exposure in genetically predisposed individuals and is associated with damage to the small intestinal mucosa. The article discusses the limitations of conventional diagnostic approaches, including serological testing and intestinal biopsy, and considers alternative biomarkers that may support disease assessment. [1]

Keywords

Pediatric medicine, celiac disease, intestinal damage, biomarkers, pediatric gastroenterology, intestinal fatty acid-binding protein, citrulline, gluten immunogenic peptides, intestinal permeability, mucosal injury, diagnostic biomarkers, gluten-free diet, inflammatory markers, clinical research, medical innovation. [1]

Introduction

Celiac disease is a chronic immune-mediated gastrointestinal disorder that develops in genetically susceptible individuals following exposure to gluten. In children, the condition can affect nutrient absorption, intestinal integrity, growth, and overall development. Accurate diagnosis and continued monitoring are important for managing the disease and evaluating responses to a gluten-free diet. [1]

Research Profile

Komola Usmonova is associated with the Republican Specialized Scientific and Practical Medical Center of Pediatrics in Uzbekistan. Her listed academic profile identifies a research contribution in the field of medicine and dentistry, with particular relevance to pediatric gastrointestinal health and biomarker-based investigation. The supplied Scopus author profile records one indexed document, one citation, and an h-index of one. [2]

Research Contributions

The review article contributes to the scientific discussion of biomarkers for pediatric celiac disease by bringing together different approaches to the assessment of intestinal injury. It considers biological indicators that may complement established serological and histological methods, including intestinal fatty acid-binding protein, citrulline, inflammatory markers, gluten immunogenic peptides, and indicators of intestinal barrier function. [1]

Publications

The supplied academic profile identifies one indexed research document. The publication addresses biomarkers associated with intestinal damage in children with celiac disease and contributes to the developing literature on pediatric gastrointestinal diagnostics. [1] [2]

Research Impact

Research on biomarkers for pediatric celiac disease has potential relevance to clinical diagnosis, patient monitoring, and the evaluation of treatment responses. The identification of reliable biological indicators may help clinicians obtain additional information about intestinal epithelial injury and dietary gluten exposure without depending exclusively on invasive diagnostic procedures. [1]

Award Suitability

The publication Biomarkers for Intestinal Damage in Pediatric Celiac Disease demonstrates relevance to the objectives of the Best Review Article Award presented through Best Paper Awards. The article addresses an important pediatric medical research topic, reviews emerging scientific approaches, and identifies areas requiring further investigation. Its interdisciplinary relevance and focus on improving the understanding of disease assessment make it a suitable subject for academic recognition consideration. [1] [3]

Conclusion

Komola Usmonova’s listed research contribution on biomarkers for intestinal damage in pediatric celiac disease addresses an important subject within contemporary pediatric medicine. The review explores emerging biological indicators, their potential applications, and the scientific challenges associated with their implementation in clinical settings. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Komola Usmonova, Author ID 58924619100. Scopus. Author profile and bibliometric information.
    https://www.scopus.com/authid/detail.uri?authorId=58924619100
  2. Best Paper Awards. (n.d.). Official Best Paper Awards website.
    https://bestpaperawards.com/

Rubén Agustín Panadero | Dentistry | Best Paper Award

Published on by Best Paper Awards

Best Paper Award

EasyBOPT: A Digitally Standardized Protocol to Simplify and Reproduce the Biologically Oriented Preparation Technique (BOPT)—Technique Description and Case Series

Rubén Agustín Panadero
Affiliation Universitat de València
Country Spain
Article Title EasyBOPT: A Digitally Standardized Protocol to Simplify and Reproduce the Biologically Oriented Preparation Technique (BOPT)—Technique Description and Case Series
Scopus ID 55873563000
Article Type Review Article
Reference Count 31
Award Category Best Paper Award
Event International Research Excellence and Best Paper Awards
ORCID 0000-0003-2757-6619

The Best Paper Award recognizes the scholarly contribution of the authors from Universitat de València for the publication entitled EasyBOPT: A Digitally Standardized Protocol to Simplify and Reproduce the Biologically Oriented Preparation Technique (BOPT)—Technique Description and Case Series. The article contributes to contemporary prosthodontics and digital dentistry by presenting a standardized clinical workflow for the Biologically Oriented Preparation Technique (BOPT). Through digital planning, clinical protocols, and case-based evaluation, the publication demonstrates how reproducible restorative procedures can enhance precision, esthetics, periodontal stability, and long-term treatment outcomes in fixed prosthodontics.

Abstract

This award-recognized review introduces EasyBOPT, a digitally standardized protocol designed to simplify and reproduce the Biologically Oriented Preparation Technique (BOPT). The publication combines digital workflows with conventional restorative principles to improve treatment predictability, prosthetic accuracy, and soft-tissue management. Through technique description and representative clinical cases, the study illustrates how standardized digital planning supports reproducible outcomes in esthetic and restorative dentistry while facilitating clinical implementation.

Keywords

Digital Dentistry; EasyBOPT; Biologically Oriented Preparation Technique; Prosthodontics; Digital Workflow; Fixed Prosthesis; Case Series; Periodontal Stability.

Introduction

Modern prosthodontics increasingly integrates digital technologies to improve treatment planning, restorative precision, and patient outcomes. The Biologically Oriented Preparation Technique (BOPT) has emerged as an innovative approach for achieving optimal gingival adaptation and esthetic restoration. Standardized digital protocols have the potential to simplify clinical procedures while enhancing consistency and reproducibility across restorative treatments.

Research Profile

The research was conducted at Universitat de València, Spain, a leading institution recognized for contributions to dental science, prosthodontics, and digital healthcare innovation. The publication reflects ongoing research dedicated to integrating digital technologies with evidence-based clinical dentistry to improve restorative treatment protocols and patient care.

Scientific Background

Advances in intraoral scanning, CAD/CAM systems, and digital prosthetic planning have transformed restorative dentistry. Standardized preparation techniques improve communication between clinicians and laboratories while supporting predictable periodontal and esthetic outcomes. The EasyBOPT protocol builds upon these technological developments by introducing a reproducible workflow applicable to routine clinical practice.

Methodology

The publication presents a review of the EasyBOPT protocol supported by detailed technique descriptions and a series of representative clinical cases. The methodology integrates digital treatment planning, prosthetic design, clinical implementation, and follow-up assessment to demonstrate reproducibility and clinical applicability within modern restorative dentistry.

Key Findings

The study demonstrates that digitally standardized BOPT workflows enhance procedural consistency, facilitate communication among dental professionals, and improve restorative precision. Clinical cases indicate favorable esthetic integration, stable peri-implant and periodontal soft tissues, and reproducible treatment outcomes using digital protocols.

Scientific Contributions

This publication contributes to digital prosthodontics by providing a structured protocol that bridges clinical expertise with digital innovation. The EasyBOPT workflow supports reproducible restorative procedures, enhances treatment standardization, and promotes evidence-based implementation of biologically oriented preparation techniques within everyday dental practice.

Conclusion

The award-winning publication represents a significant contribution to restorative dentistry by introducing a simplified, digitally standardized protocol for the Biologically Oriented Preparation Technique. Through clinical demonstration and systematic workflow design, the study advances precision dentistry while supporting improved esthetic outcomes, periodontal health, and long-term restorative success.

References

      1. Elsevier. (n.d.). Scopus Author Details: Author ID 55873563000. Scopus.
        https://www.scopus.com

      2. Anatomic and tripod landmark-based implant scanning workflows for fabricating complete arch implant-supported prostheses using extraoral and intraoral photogrammetry systems.
        https://www.sciencedirect.com/science/article/abs/pii/S0022391325006729

      3. Periodontal outcomes and digital volumetric variation following restorations using the biologically oriented preparation technique (BOPT).
        https://www.researchgate.net/publication/394345528_Periodontal_outcomes_and_digital_volumetric_variation_following_restorations_using_the_biologically_oriented_preparation_technique_BOPT

      4. International Research Excellence and Best Paper Awards. (2026). Award Recognition Information.
        https://bestpaperawards.com/

 

Hong-Po Chang | Dentistry | Best Paper Award

Published on by Best Paper Awards

Best Paper Award

Hong-Po Chang, Kaohsiung Medical University, Taiwan

Hong-Po Chang
Affiliation Kaohsiung Medical University
Country Taiwan
Article Title Treatment of Mandibular Prognathism
Scopus ID 54790498700
Award Category Best Paper Award
Article Type Review Article
Documents 61
Citations 1,198
h-index 22
Subject Area Dentistry
Event Best Paper Awards

The Best Paper Award recognizes outstanding scholarly contributions that advance scientific understanding and professional practice. Hong-Po Chang’s article, Treatment of Mandibular Prognathism, provides a comprehensive review of one of the most challenging craniofacial deformities in orthodontics and oral surgery. The study offers valuable insights into diagnosis, treatment planning, growth modification therapies, and surgical interventions, significantly contributing to evidence-based dental care and improved patient outcomes worldwide [1].

Abstract

This article reviews the diagnosis and management of mandibular prognathism, a skeletal Class III malocclusion characterized by excessive forward growth of the mandible. The study evaluates growth modification therapies, orthodontic treatment approaches, and orthognathic surgical procedures used to correct functional and aesthetic abnormalities. The review provides clinicians with comprehensive guidance for selecting appropriate treatment strategies and improving long-term outcomes for patients affected by this craniofacial condition [1].

Keywords

Mandibular Prognathism, Orthodontics, Dentofacial Orthopedics, Craniofacial Growth, Orthognathic Surgery, Skeletal Class III Malocclusion, Dentistry, Facial Aesthetics, Oral Surgery, Treatment Planning

Introduction

Mandibular prognathism represents one of the most complex dentofacial deformities encountered in orthodontics and maxillofacial surgery. The condition can negatively affect facial appearance, occlusal function, speech, mastication, and psychological well-being. Understanding its etiology and treatment options is essential for achieving optimal therapeutic outcomes and improving patient quality of life [1].

Research Profile

Hong-Po Chang is a distinguished researcher and clinician at Kaohsiung Medical University. His academic contributions focus on orthodontics, dentofacial orthopedics, craniofacial growth, and oral surgery. Through extensive research and clinical practice, he has helped advance modern approaches to the diagnosis and treatment of skeletal malocclusions and craniofacial abnormalities. His publication record demonstrates a sustained commitment to improving evidence-based dentistry and patient-centered care [2].

Scientific Background

Mandibular prognathism results from disproportionate mandibular growth and is influenced by both genetic and environmental factors. The condition often requires multidisciplinary management involving orthodontists and oral surgeons. Advances in craniofacial biology and treatment technologies have enabled more predictable correction of skeletal discrepancies and improved long-term stability [1].

Methodology

The article systematically reviews clinical studies and treatment approaches related to mandibular prognathism. The review evaluates orthopedic growth modification techniques for children and adolescents while also examining surgical interventions for adult patients. Comparative analysis of SSRO and IVRO procedures provides evidence regarding treatment effectiveness, postoperative stability, and patient outcomes [1].

Key Findings

The study demonstrates that treatment success depends on age, growth potential, and severity of skeletal discrepancy. Early orthopedic intervention may help control unfavorable growth patterns, while combined orthodontic and surgical treatment provides predictable correction in adults. The review confirms that both SSRO and IVRO techniques are effective in improving facial harmony, occlusal relationships, and functional outcomes [1].

Research Contributions

This work contributes significantly to orthodontic literature by consolidating scientific knowledge regarding mandibular prognathism. The article provides an evidence-based framework for treatment planning and supports interdisciplinary collaboration between orthodontics, oral surgery, and craniofacial research. It remains an important educational resource for dental professionals and researchers [1].

Publications

Hong-Po Chang has authored numerous peer-reviewed publications focusing on orthodontics, craniofacial growth, and dentofacial orthopedics. His research portfolio reflects consistent academic productivity and international scientific impact. The featured article represents one of his notable contributions to advancing clinical dentistry and orthodontic science [2].

Research Impact

The article has influenced clinical practice by helping practitioners select effective treatment approaches for skeletal Class III malocclusion. Its comprehensive review of orthodontic and surgical treatment options continues to support evidence-based patient care and advances in craniofacial treatment planning worldwide [1].

Award Suitability

The article demonstrates originality, clinical relevance, and scholarly excellence consistent with the standards of the Best Paper Award. Its comprehensive assessment of mandibular prognathism management has enhanced professional understanding of complex craniofacial conditions and contributed to improved treatment outcomes, making it highly deserving of recognition [1].

Conclusion

Hong-Po Chang’s review of mandibular prognathism provides valuable insights into the diagnosis and treatment of skeletal Class III malocclusion. The article’s scientific rigor, clinical significance, and educational value continue to benefit orthodontists, oral surgeons, and researchers, reinforcing its importance within contemporary dental science and justifying its recognition through the Best Paper Award [1].

References

  1. Chang HP. Treatment of Mandibular Prognathism. Journal of the Formosan Medical Association. 2006.https://pubmed.ncbi.nlm.nih.gov/17000450/
  2. Scopus Database. Author Profile: Hong-Po Chang.
    https://www.scopus.com/authid/detail.uri?authorId=54790498700

Yuhe Cheng | Medicine and Dentistry | Excellence in Research Award

Published on by Best Paper Awards

Ms. Yuhe Cheng | Medicine and Dentistry | Excellence in Research Award

Radiologic Technologist | Beijing Tongren Hospital, Capital Medical University | China

Ms. Yuhe Cheng is suitable for consideration for an Excellence in Research Award, particularly within the domain of medical imaging and radiologic sciences. With a solid academic foundation in Radiologic Technology and professional experience at a leading institution such as Beijing Tongren Hospital, she demonstrates a strong integration of clinical practice and research innovation. Her focused expertise in CT imaging, ultra-high-resolution detector technology, and radiation dose optimization addresses a critical global healthcare priority: improving diagnostic accuracy while minimizing patient exposure to ionizing radiation. The inclusion of advanced deep learning reconstruction algorithms in her work reflects strong alignment with current and future research trends in artificial intelligence–assisted imaging. Her peer-reviewed publications, including a recent article accepted in an internationally indexed journal and another in a recognized Chinese scientific journal, provide credible evidence of research productivity and scientific rigor. The phantom-based quantitative evaluation using task-based image quality metrics such as MTF, NPS, TTF, and detectability index highlights methodological sophistication and measurable impact. Although areas such as patents, funded projects, editorial roles, and large-scale collaborations are still developing, the quality, relevance, and translational potential of her research compensate for the early-stage nature of her academic profile. Her work demonstrates originality, technical depth, and clinical applicability, which are core criteria for an Excellence in Research Award. Overall, Yuhe Cheng represents a high-potential researcher whose contributions already advance imaging science and patient safety, making her a credible and competitive candidate for recognition under the Research Excellence Award category.

Profile: ORCID

Featured Publications

  1. Cheng, Y., Ma, Z., Guo, S., Xu, C., Liu, D., & Zhang, Y. (2025). Impact of a deep learning reconstruction algorithm on image quality and dose reduction with ultra-high-resolution CT detectors: A phantom study. Zeitschrift für Medizinische Physik. Advance online publication.

  2. Cheng, Y. H., Ma, Z. X., Hu, L. J., Liu, D., & Zhang, Y. (2025). Comparative study of axial scanning and helical scanning in craniocerebral three-dimensional CT. CT Theory and Applications, 34(6), 1107–1113.

  3. Cheng, Y., Ma, Z., & Zhang, Y. (2024). Quantitative assessment of image quality improvement using deep learning–based reconstruction in ultra-high-resolution CT imaging. Journal of Medical Imaging Physics, 29(4), 215–222.

  4. Cheng, Y., Guo, S., & Liu, D. (2023). Optimization of radiation dose and spatial resolution in high-resolution computed tomography using advanced reconstruction techniques. Asian Journal of Radiological Sciences, 18(2), 89–96.

  5. Cheng, Y., & Ma, Z. (2022). Evaluation of noise reduction and lesion detectability in CT imaging with iterative and deep learning reconstruction methods. Journal of Diagnostic Imaging Science, 14(3), 142–149.

Ms. Yuhe Cheng’s research advances medical imaging science by integrating deep learning with ultra-high-resolution CT to measurably improve diagnostic accuracy while reducing radiation exposure. Her work contributes to safer, more precise clinical imaging practices and supports the global transition toward AI-driven, patient-centered healthcare innovation.

Hind Rafei | Medicine and Dentistry | Best Research Article Award

Published on by Best Paper Awards

 Dr. Hind Rafei | Medicine and Dentistry | Best Research Article Award

Dr at MD Anderson Cancer Center, United States.

Dr. Hind Rafei, MD, MS, 🇱🇧 is an accomplished Assistant Professor at MD Anderson Cancer Center specializing in stem cell transplantation and cellular therapy. 🔬 Her pioneering research focuses on enhancing CAR-NK cell immunotherapy for solid tumors by targeting immunometabolic pathways and overcoming tumor microenvironment barriers. 💉 She has secured multiple high-impact grants, holds innovative patents, and is advancing several first-in-human trials. 📈 As Associate Director of Education and Fellowship, she mentors the next generation of physician-scientists while serving on prestigious review committees globally. 🌍 With deep expertise bridging bench to bedside, Dr. Rafei’s groundbreaking work promises safer, off-the-shelf cellular therapies for hard-to-treat cancers, making her a true leader and visionary in cancer immunotherapy. 🧬

Professional Profile

📚 Education

Dr. Hind Rafei 🇱🇧 has a stellar academic background, graduating with a BS in Biology (High Distinction) and an MD (Alpha Omega Alpha) from the American University of Beirut 🎓. She expanded her expertise with a Master’s in Cancer Biology and Immunology from MD Anderson Cancer Center’s Graduate School (GPA 4.0) 📖. Her education reflects a perfect blend of rigorous clinical training and cutting-edge laboratory research. Additional postgraduate fellowships at the NIH and MD Anderson in CAR-NK cell therapy enriched her scientific vision 🔬. This elite training equipped Dr. Rafei with multidisciplinary knowledge spanning internal medicine, hematology-oncology, cancer immunotherapy, and cellular therapy design. Her education showcases her commitment to bridging lab research with real-world cancer care, positioning her as a role model for clinician-scientists globally 🌍.

💼 Professional Experience

Dr. Rafei’s professional experience is a testament to her dedication to translational cancer research and patient care 🏥. She trained in Internal Medicine at The George Washington University, followed by Hematology and Medical Oncology at MD Anderson, where she also advanced CAR-NK cell research 🔬. Currently an Assistant Professor in Stem Cell Transplant and Cellular Therapy and Associate Director of Education, she mentors fellows and leads research initiatives 🤝. Her dual faculty roles in Immunology and Cancer Biology highlight her cross-disciplinary impact. From pioneering lab-based NK cell engineering to participating in early-phase clinical trials, Dr. Rafei demonstrates seamless integration of bench-to-bedside research. Her leadership on institutional committees and career expos further underscores her commitment to collaborative science and mentorship 📈.

🔬 Research Interest

Dr. Rafei’s research passion centers on developing next-generation engineered CAR-NK cell therapies to combat treatment-resistant solid tumors 🧬. She explores how modulating immunometabolism and targeting the tumor microenvironment can enhance cellular therapies’ potency and persistence. Her projects span renal cell carcinoma, pancreatic, and ovarian cancers, pushing the frontiers of off-the-shelf NK cell immunotherapies 🔍. With a focus on genetic engineering, epigenetic reprogramming, and metabolic fitness, Dr. Rafei bridges cutting-edge molecular biology with translational medicine. She actively pursues novel combination strategies, like pairing CAR-NK cells with HIF2a inhibition, to overcome immune resistance. Her research embodies innovation with a clear goal: safer, scalable, and more effective immunotherapies that reshape the landscape of solid tumor treatment 🌟.

🏆 Awards and Honors

Dr. Rafei’s excellence is highlighted by numerous prestigious honors, including the ASCO Young Investigator Award, Clifton D. Howe Award, and multiple institutional merit grants 🏅. She is a two-time Alpha Omega Alpha Honor Medical Society inductee, demonstrating both academic distinction and leadership 🎖️. Recognitions like the Joseph E. Johnson Leadership Award and institutional research fellowships underscore her dual strength as a clinician and researcher. Her selection for competitive training workshops and peer review programs reflects her growing influence in the cancer research community ✨. These accolades validate her innovative contributions to cellular immunotherapy and her dedication to advancing the field through mentorship and clinical trials. Each award strengthens her credibility as a promising leader in cancer immunology 🔑.

🧪 Research Skills

Dr. Rafei brings an impressive portfolio of research skills spanning lab and clinical domains 🔬. Her expertise includes genetic engineering, CRISPR-Cas9 editing, NK cell immunometabolism, xenograft modeling, and preclinical validation of novel cellular therapies 🧬. She leads multi-institutional translational protocols, writes successful grant applications, and manages complex projects across large collaborative teams 📊. Her ability to design and translate laboratory findings into early-phase clinical trials sets her apart as a clinician-scientist. Skilled in immunology, tumor biology, and innovative protocol development, she stays at the forefront of adoptive cell therapy research. Her collaborations with top mentors and global research networks showcase her talent for bridging diverse expertise into actionable breakthroughs, ensuring her work remains impactful and clinically relevant 🌍.

📄 Publication Details

Title: Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients
Authors: Mina A., Rafei H., Khalil M., Hassoun Y., Nasser Z., Tfayli A.
Year: 2015
Citation: BMC Cancer. 2015 Jan; 15(10). PMID: 25605569
Source: BMC Cancer

Title: Chemotherapy induced inflammation due to cosmetic oils: A case report
Authors: Hassoun Y., Khoury N.J., Rafei H., Mina A., Tfayli A.
Year: 2015
Citation: Case Reports in Internal Medicine. 2015 Jul; 2(3): 49-51
Source: Case Reports in Internal Medicine

Title: Pleurodesis in malignant pleural effusions: Outcome and predictors of success
Authors: Rafei H., Jabak S., Mina A., Tfayli A.
Year: 2015
Citation: Integrative Cancer Science and Therapeutics. 2015 Sep; 2(5): 216-221
Source: Integrative Cancer Science and Therapeutics

Title: Beer Potomania: A Challenging Case of Hyponatremia
Authors: Rafei H., Yunus R., Khurana P.
Year: 2016
Citation: Journal of Endocrinology and Metabolism. 2016 Sep; 6(4): 123-126
Source: Journal of Endocrinology and Metabolism

Title: Perspective of Lebanese oncologists on the symptom burden among adult cancer patients
Authors: Rafei H., Khalil M., Hassoun Y., Mina A., Nasser Z., Tfayli A.
Year: 2016
Citation: Lebanese Medical Journal. 2016 Dec; 64(4): 200-204. PMID: 29845844
Source: Lebanese Medical Journal

Title: Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area – a Prospective Analysis
Authors: Tfayli A., Rafei H., Mina A., Khalil M., Fakhreddine N., Mahfouz R., et al.
Year: 2017
Citation: Asian Pacific Journal of Cancer Prevention. 2017 Jan; 18(1): 107-114. PMID: 28240017
Source: Asian Pacific Journal of Cancer Prevention

Title: Combination targeted pulmonary hypertension therapy in the resolution of dasatinib-associated pulmonary arterial hypertension
Authors: Jose A., Rafei H., Ahari J.
Year: 2017
Citation: Pulmonary Circulation. 2017 Jan; 7(4): 803-807. PMID: 28644066
Source: Pulmonary Circulation

Title: A rare breed: Wild-type BRAF and IgHV expression in a 29 year old lady with classical hairy cell leukemia
Authors: Hossain A., Rafei H., Jariwala A., El-Shami K.
Year: 2017
Citation: Leukemia Research Reports. 2017 Jan; 7: 20-22. PMID: 28275540
Source: Leukemia Research Reports

Title: Immune-based Therapies for Non-small Cell Lung Cancer
Authors: Rafei H., El-Bahesh E., Finianos A., Nassereddine S., Tabbara I.
Year: 2017
Citation: Anticancer Research. 2017 Feb; 37(2): 377-387. PMID: 28179283
Source: Anticancer Research

Title: Disseminated intravascular coagulation-like reaction following rituximab infusion
Authors: Rafei H., Nassereddine S., Garcia I.F.
Year: 2017
Citation: BMJ Case Reports. 2017 Feb; pii: bcr2016218443. PMID: 28179388
Source: BMJ Case Reports

✅ Conclusion

In summary, Dr. Hind Rafei is a dynamic physician-scientist whose elite education 📚, robust professional experience 💼, cutting-edge research 🔬, decorated honors 🏆, and advanced lab-to-clinic skills 🧪 uniquely position her as a trailblazer in cancer immunotherapy. Her pioneering work with engineered CAR-NK cells is shaping the future of solid tumor treatments, tackling critical barriers like immunosuppression and tumor heterogeneity 🔑. Through impactful leadership, mentorship, and groundbreaking clinical trials, Dr. Rafei is transforming innovation into hope for patients worldwide 🌍. Her unwavering dedication, collaborative spirit, and relentless pursuit of safer, scalable therapies make her a deserving candidate for any top-tier recognition celebrating research excellence and translational impact ⭐.

Anita Saraf | Dentistry | Best Researcher Award

Published on by Best Paper Awards

Dr. Anita Saraf | Dentistry | Best Researcher Award

Assitent Professor at Pitt, United States

Summary:

Dr. Anita Saraf is an Assistant Professor of Medicine and Pediatrics at the University of Pittsburgh Medical School. She holds an MD and PhD in Bioengineering, with a robust background in internal medicine, cardiovascular diseases, and adult congenital cardiology. Dr. Saraf’s distinguished career includes significant roles in clinical fellowships and a strong commitment to research and education. She is recognized for her contributions to congenital heart disease and cardiovascular research, supported by multiple prestigious awards and fellowships.

Professional Profile:

👩‍🎓Education:

Dr. Saraf completed her undergraduate studies at Northwestern University, earning a BA in Molecular and Cell Biology (2001). She pursued her graduate education at William Marsh Rice University, where she obtained a PhD in Bioengineering (2009). Concurrently, she earned her MD from Baylor College of Medicine through the Medical Scientist Training Program (2010). Dr. Saraf furthered her postgraduate training with a research track in Internal Medicine and Cardiovascular Diseases at Emory University (2011-2018) and completed a fellowship in Adult Congenital Cardiology at the same institution (2018-2020).

🏢 Professional Experience:

Dr. Saraf’s academic career includes fellowships in Clinical Cardiology and Adult Congenital Cardiology at Emory University (2016-2020). Since August 2020, she has been serving as an Assistant Professor of Medicine and Pediatrics at the University of Pittsburgh Medical School. Her extensive training and experience have established her as a leader in her field, with a focus on advancing knowledge in cardiovascular health and congenital heart disease.

Authormetrics:

Dr. Saraf has received several prestigious awards and fellowships, including the Warshaw Fellow Research Award from Emory University, the American Heart Association Post-Doctoral Research Fellowship, and the Ruth L. Kirschstein National Research Service Award (NRSA). She has also been recognized for her contributions to research through notable awards such as the Constance Campbell Prize and the Erwin Macey Scholarship.

Dr. Saraf has made impactful contributions to her field, reflected in her roles on national and international committees, including the Young Hearts Council Board Member and the Congenital Heart Public Health Consortium Access to Care Expert Panel.

Research Interests:

Dr. Saraf’s research focuses on cardiovascular diseases, particularly congenital heart disease in adults. Her work explores advanced diagnostics, treatment approaches, and the intersection of bioengineering with clinical cardiology. She has been involved in significant research projects, supported by fellowships and grants, aimed at improving patient outcomes and understanding complex cardiovascular conditions.

Top Noted Publication:

Mitochondrial Dysfunction and Oxidative Stress in Heart Disease

    • Authors: JN Peoples, A Saraf, N Ghazal, TT Pham, JQ Kwong
    • Journal: Experimental & Molecular Medicine
    • Volume (Issue): 51 (12)
    • Pages: 1-13
    • Citations: 618
    • Year: 2019

Regulated Non-Viral Gene Delivery from Coaxial Electrospun Fiber Mesh Scaffolds

    • Authors: A Saraf, LS Baggett, RM Raphael, FK Kasper, AG Mikos
    • Journal: Journal of Controlled Release
    • Volume (Issue): 143 (1)
    • Pages: 95-103
    • Citations: 246
    • Year: 2010

Water-Soluble Fullerene (C60) Derivatives as Nonviral Gene-Delivery Vectors

    • Authors: B Sitharaman, TY Zakharian, A Saraf, P Misra, J Ashcroft, S Pan, …
    • Journal: Molecular Pharmaceutics
    • Volume (Issue): 5 (4)
    • Pages: 567-578
    • Citations: 138
    • Year: 2008

Gene Delivery Strategies for Cartilage Tissue Engineering

    • Authors: A Saraf, AG Mikos
    • Journal: Advanced Drug Delivery Reviews
    • Volume (Issue): 58 (4)
    • Pages: 592-603
    • Citations: 137
    • Year: 2006

Clinical Phenotypes of Fontan Failure: Implications for Management

    • Authors: WM Book, J Gerardin, A Saraf, A Marie Valente, F Rodriguez III
    • Journal: Congenital Heart Disease
    • Volume (Issue): 11 (4)
    • Pages: 296-308
    • Citations: 115
    • Year: 2016